David Cory's Insider Trades & SAST Disclosures

David Cory's most recent trade in Eiger BioPharmaceuticals Inc was a trade of 48,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 29, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eiger BioPharmaceuticals Inc
David A. Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 48,750 48,750 - - Stock Option (Right to Buy)
Eiger BioPharmaceuticals Inc
David A. Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 281,000 281,000 - - Stock Option (Right to Buy)
Eiger BioPharmaceuticals Inc
David A. Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 47,000 117,846 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades